From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?
- PMID: 35956130
- PMCID: PMC9369634
- DOI: 10.3390/jcm11154515
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?
Abstract
The biomarkers era grew in the last two decades when several technical and methodological advances have improved the research in neurodegenerative diseases [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- De Marchi F., Munitic I., Amedei A., Berry J.D., Feldman E.L., Aronica E., Nardo G., Van Weehaeghe D., Niccolai E., Prtenjaca N., et al. Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact. Neurosci. Biobehav. Rev. 2021;127:958–978. doi: 10.1016/j.neubiorev.2021.06.027. - DOI - PMC - PubMed
-
- Jack C.R., Jr., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B., Holtzman D.M., Jagust W., Jessen F., Karlawish J., et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement. 2018;14:535–562. doi: 10.1016/j.jalz.2018.02.018. - DOI - PMC - PubMed
-
- Mattsson-Carlgren N., Grinberg L.T., Boxer A., Ossenkoppele R., Jonsson M., Seeley W., Ehrenberg A., Spina S., Janelidze S., Rojas-Martinex J., et al. Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration. Neurology. 2022;98:e1137–e1150. doi: 10.1212/WNL.0000000000200040. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
